Regentis Biomaterials Ltd. filed a report on January 29, 2026, regarding the expansion of its Phase III GelrinC Clinical Site Network by adding several leading orthopedic centers in the U.S.
AI Assistant
REGENTIS BIOMATERIALS LTD
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.